Back التطعيم ضد كوفيد-19 في الهند Arabic Vacunación contra la COVID-19 en India Spanish واکسیناسیون کووید ۱۹ در هند Persian भारत में कोविड-१९ टीकाकरण Hindi Vaksinasi Covid-19 di India ID 인도의 코로나19 예방접종 Korean ഇന്ത്യയിലെ കോവിഡ് -19 പ്രതിരോധ കുത്തിവെപ്പ് Malayalam இந்தியாவில் கோவிட்-19 தடுப்பு மருந்து Tamil Вакцинація проти COVID-19 в Індії Ukrainian
 | This article needs additional citations for verification. (October 2023) |
 Per capita fully vaccination map as of 4 April 2023 | |
| Date | 16 January 2021 – present (3 years, 299 days ago) |
|---|---|
| Location |  India |
| Cause | COVID-19 pandemic in India |
| Target | Immunisation of Indians against COVID-19 |
| Budget | ₹35,000 crore (US$4.2 billion)[1] |
| Organised by | Government of India Indian Council of Medical Research State governments of India |
| Participants |
|
| Outcome |
|
| Website | MoHFW |
| As on 4th March 2023 (07:00AM) | |
| Part of a series on the |
| COVID-19 pandemic |
|---|
 |
|
.svg){kind=small} COVID-19 portal |
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines.[2][3] In India, 95% of the eligible population (12+) has received at least one shot, and 88% of the eligible population (12+) is fully vaccinated.[4][5]
India initially approved the Oxford–AstraZeneca vaccine (manufactured under license by Serum Institute of India under the trade name Covishield) and Covaxin (a vaccine developed locally by Bharat Biotech). They have since been joined by the Sputnik V (manufactured under license by Dr. Reddy's Laboratories, with additional production from Serum Institute of India being started in September[6][7]), Moderna vaccines, Johnson & Johnson vaccine and ZyCoV-D (a vaccine locally developed by Zydus Cadila)[a][b] and other vaccine candidates undergoing local clinical trials.
According to a June 2022 study published in The Lancet, COVID-19 vaccination in India prevented an additional 4.2 million deaths from December 8, 2020, to December 8, 2021.[8][9]
- ^ "Budget 2021: Two more coronavirus vaccines soon, reveals FM Nirmala Sitharaman". Businesstoday.in. Archived from the original on 13 April 2021. Retrieved 13 March 2021.
- ^ "Vaccination state wise". Ministry of Health and Family Welfare. Archived from the original on 30 January 2020. Retrieved 4 March 2023. (NB: The data on this site change daily)
- ^ "Vaccination Statistics". vaccinate-india.in. Archived from the original on 8 April 2022. Retrieved 2 December 2022.
- ^ "Covid-19 Vaccination in India". Cowin. Archived from the original on 9 February 2021. Retrieved 30 March 2021.
- ^ Cite error: The named reference
vaccinate-indiawas invoked but never defined (see the help page). - ^ "Serum Institute gets DCGI's nod to manufacture Covid vaccine Sputnik V in India". mint. 4 June 2021. Archived from the original on 29 July 2022. Retrieved 23 August 2021.
- ^ rdif.ru: press release Archived 24 January 2022 at the Wayback Machine
- ^ Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC (23 June 2022). "Global impact of the first year of COVID-19 vaccination: a mathematical modelling study". The Lancet Infectious Diseases. 22 (9): 1293–1302. doi:10.1016/s1473-3099(22)00320-6. ISSN 1473-3099. PMC 9225255. PMID 35753318. Archived from the original on 29 June 2022. Retrieved 27 June 2022.
- ^ "COVID-19 vaccines saved nearly 20 million lives in a year, study says". CBS News. 24 June 2022. Archived from the original on 29 June 2022. Retrieved 27 June 2022.
Cite error: There are <ref group=lower-alpha> tags or {{efn}} templates on this page, but the references will not show without a {{reflist|group=lower-alpha}} template or {{notelist}} template (see the help page).